New patent for Strongbridge drug RECORLEV April 14, 2024 AutoBot News 0 Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. It is available from one supplier. There are seven patents protecting… Source